Protocol digest of a single-arm confirmatory trial for less intensive postoperative surveillance in low-risk colorectal cancer patients: JCOG1915 (less study).

IF 2.2 4区 医学 Q3 ONCOLOGY
Yuta Sekino, Konosuke Moritani, Junki Mizusawa, Dai Shida, Tsukamoto Shunsuke, Tetsuya Hamaguchi, Atsuo Takashima, Akio Shiomi, Masaaki Ito, Yuichi Takayama, Makoto Kinouchi, Shin Fujita, Manabu Shiozawa, Hideki Ueno, Satoshi Ikeda, Yasumasa Takii, Yusuke Sano, Tomoko Kataoka, Haruhiko Fukuda, Yukihide Kanemitsu
{"title":"Protocol digest of a single-arm confirmatory trial for less intensive postoperative surveillance in low-risk colorectal cancer patients: JCOG1915 (less study).","authors":"Yuta Sekino, Konosuke Moritani, Junki Mizusawa, Dai Shida, Tsukamoto Shunsuke, Tetsuya Hamaguchi, Atsuo Takashima, Akio Shiomi, Masaaki Ito, Yuichi Takayama, Makoto Kinouchi, Shin Fujita, Manabu Shiozawa, Hideki Ueno, Satoshi Ikeda, Yasumasa Takii, Yusuke Sano, Tomoko Kataoka, Haruhiko Fukuda, Yukihide Kanemitsu","doi":"10.1093/jjco/hyaf077","DOIUrl":null,"url":null,"abstract":"<p><p>The Japanese Society for Cancer of the Colon and Rectum guidelines recommend intensive surveillance for curatively resected pathological stage I-III colorectal cancer. However, there is still no global consensus on the optimal method, duration, or frequency of surveillance, and no clinical trials have demonstrated the usefulness of surveillance. We are conducting a clinical trial to confirm the efficacy of less-intensive surveillance after R0 resection with lymph node dissection for stage I or low-risk stage II colorectal cancer in patients without risk factors for recurrence. If this less intensive surveillance method proves effective, medical costs will be considerably reduced. The primary endpoint is overall survival. A total of 680 patients will be enrolled from 59 institutions over 2 years. This trial has been registered at the Japan Registry of Clinical Trials (jRCT) as study number jRCT1030220350.</p>","PeriodicalId":14656,"journal":{"name":"Japanese journal of clinical oncology","volume":" ","pages":"970-974"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12319228/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese journal of clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jjco/hyaf077","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The Japanese Society for Cancer of the Colon and Rectum guidelines recommend intensive surveillance for curatively resected pathological stage I-III colorectal cancer. However, there is still no global consensus on the optimal method, duration, or frequency of surveillance, and no clinical trials have demonstrated the usefulness of surveillance. We are conducting a clinical trial to confirm the efficacy of less-intensive surveillance after R0 resection with lymph node dissection for stage I or low-risk stage II colorectal cancer in patients without risk factors for recurrence. If this less intensive surveillance method proves effective, medical costs will be considerably reduced. The primary endpoint is overall survival. A total of 680 patients will be enrolled from 59 institutions over 2 years. This trial has been registered at the Japan Registry of Clinical Trials (jRCT) as study number jRCT1030220350.

Abstract Image

低风险结直肠癌患者术后低强度监测的单臂验证性试验方案摘要:JCOG1915(较少研究)。
日本结直肠癌协会的指南建议对治疗切除的病理I-III期结直肠癌进行强化监测。然而,对于监测的最佳方法、持续时间或频率,仍然没有全球共识,也没有临床试验证明监测的有效性。我们正在进行一项临床试验,以确认对无复发危险因素的I期或低危II期结直肠癌患者进行R0切除合并淋巴结清扫后低强度监测的有效性。如果这种不那么密集的监测方法被证明是有效的,医疗费用将大大降低。主要终点是总生存期。在2年的时间里,来自59家机构的680名患者将被纳入研究。该试验已在日本临床试验注册中心(jRCT)注册,研究编号为jRCT1030220350。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
8.30%
发文量
177
审稿时长
3-8 weeks
期刊介绍: Japanese Journal of Clinical Oncology is a multidisciplinary journal for clinical oncologists which strives to publish high quality manuscripts addressing medical oncology, clinical trials, radiology, surgery, basic research, and palliative care. The journal aims to contribute to the world"s scientific community with special attention to the area of clinical oncology and the Asian region. JJCO publishes various articles types including: ・Original Articles ・Case Reports ・Clinical Trial Notes ・Cancer Genetics Reports ・Epidemiology Notes ・Technical Notes ・Short Communications ・Letters to the Editors ・Solicited Reviews
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信